🇺🇸 FDA
Patent

US 10982203

Modified factor IX polypeptides and uses thereof

granted A61KA61K38/4846A61K48/00

Quick answer

US patent 10982203 (Modified factor IX polypeptides and uses thereof) held by Catalyst Biosciences, Inc. expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K38/4846, A61K48/00, A61P, A61P7/04